论文部分内容阅读
目的观察急性心肌梗死患者静脉溶栓治疗的临床疗效。方法回顾分析56例确诊为AMI且符合溶栓条件的患者进行溶栓以及规范化治疗的临床资料。结果 56例患者中32例发病6h内溶栓,其中29例溶解,3例未通;24例患者发病6-24h溶栓,其中16例溶解,8例未通。结论早期规范的溶栓治疗是治疗AMI的关键,尿激酶静脉溶栓治疗是恢复血管灌注的有效手段,价格便宜,安全、有效,值得临床推广。
Objective To observe the clinical effect of intravenous thrombolysis in patients with acute myocardial infarction. Methods Retrospective analysis of 56 cases of patients diagnosed with AMI and meet thrombolytic conditions in patients with thrombolysis and standardization of clinical data. Results Of the 56 patients, 32 patients developed thrombolysis within 6h, of which 29 were dissolved and 3 failed. Thirty-four patients developed thrombolysis 6-24h, of which 16 were dissolved and 8 failed. Conclusion Early standardized thrombolytic therapy is the key to the treatment of AMI. Thrombolytic therapy of urokinase is an effective means of restoring vascular perfusion. It is cheap, safe and effective and worthy of clinical promotion.